DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages


Patch tests

Author: Dr Ian Coulson, Consultant Dermatologist, East Lancashire NHS Trust, UK. Copy edited by Gus Mitchell. Updated December 2021


What are patch tests?

Patch testing is undertaken for the investigation and confirmation of substances that produce allergic contact dermatitis. It involves applying appropriately diluted allergens to the skin, usually on the back for convenience, for 48 hours. The patch tests are then read at 96 hours as reactions usually take 48–96 hours to develop. Positive reactions produce a patch of dermatitis at the application site of the offending allergen, which will appear as a red and possibly raised, vesicular and even blistering area.

Patch tests

Dermatitis can be thought of as being exogenous (eg, irritants, allergens, and sometimes light) or endogenous. In practice, dermatitis may be of mixed cause. Patch testing is largely of value in determining the cause of allergic contact dermatitis, and is not useful in investigating irritant dermatitis. Patch testing has some limited value in investigating some types of drug allergy, and a specialised type of patch testing is used for investigating photo contact allergy (photopatch testing).

Repeat open application testing can sometimes help identify a suspect item (usually a personal care product) if there is a delay in formal patch testing — the product is applied twice a day to a 5 cm diameter area of forearm skin for 5­–10 days. No visible redness or swelling means contact allergy to that product is unlikely. Some highly irritant products cannot safely be repeat open or occluded patch tested, as they may require appropriate dilution.

Patch tests are not the same as skin prick tests, which are used to diagnose hay fever allergy.

How is patch testing performed?

A series of allergens are applied, usually to the back, on special tapes fitted with small aluminium discs (Finn chambers) that hold the individual allergens (between 10 and 12). Anywhere between 30 and over a hundred allergens can be applied at a time.  Ideally the patch tests are applied when the dermatitis is inactive, but if the back skin is inflamed, the arms or abdominal skin can be used for application. After carefully marking the position of the patch test panels, they are removed at 48 hours, and the skin inspected 48 hours after that. 

During patch testing, it is best to:

  • Be taking less than 10 mg of oral prednisolone a day
  • Not be on an immunosuppressive agent that will reduce the reaction
  • Avoid potent topical steroids to the application site for three days before patch testing is commenced
  • Avoid bathing or showering the test area which will wash off the panels or the identification marking
  • Avoid excessive exercise that may dislodge the allergen tapes.

Antihistamines can be taken as normal as they do not interfere with the type IV hypersensitivity reaction.

How are the allergens selected?

There are several thousand potential contact allergens, but some are much more common than others. A standard series of allergens at least will usually be applied. The composition of the series varies over time and from country to country, as different allergens may become more or less important. The standard series will pick up about 70% of contact dermatitis.

Additional series of allergens may be applied, according to:

  • Occupation eg, hairdressers, bakers, dentists
  • Site of dermatitis eg, facial, lower leg, vulval, perianal, feet
  • Suspected allergen exposure eg, acrylates, epoxy resins, plastics and glues textile dyes and resins, medicaments, topical steroids
  • Patients own products eg, cosmetics, moisturisers, nail varnish, topical medicaments, gloves; these may need to be diluted to the correct patch testing strength.

At a pre-patch test consultation, the series of allergens required are selected. This is important so that potential allergens are not missed, and any product dilution arranged.

It is helpful to bring health and safety data sheets and product packaging (which may list individual allergen ingredients). If there is a suspicious product that may be the cause of dermatitis, it is important this is brought along to the doctors appointment. Patch testing may be required and its packaging will contain valuable details of its constituents.

How are patch tests interpreted?

Reactions are graded for each allergen on a spectrum as:

  • Negative
  • Irritant
  • +/- doubtful
  • + weak positive
  • ++ moderate reaction
  • +++ strong reaction.

Some allergens are coloured and will temporarily stain the skin (PPD is black, disperse blue is blue, textile resins are a variety of colours. The colour can be removed with an alcohol swab and these are not to be confused with true positive reactions.

Patch test reactions

Irritant reactions can occur in those with atopic eczema, particularly to metals (nickel, chromate and cobalt), perfumes and some rubber accelerators, and are not relevant. 

Negative results may mean that the dermatitis is endogenous or irritant in cause, or perhaps the allergen may have been missed (not considered or tested for, or may even be a novel allergen).

Positive reactions are, if possible, then interpreted as being of:

  • Current relevance — the reaction can explain dermatitis that is currently being investigated
  • Past relevance — the history reveals a past allergic dermatitis but does not explain the current episode
  • Future relevance — the allergen is likely to be encountered in the future
  • Uncertain relevance — this may change when the patient finds the identified allergen after scrutinising their personal care or occupational products
  • Potential cross reaction — eg, positive reaction to the hair dye allergen PPD may result in some people reacting to parabens (in cosmetics and sunscreens) or textile dyes.

Detailed information sheets can be given for many of the allergens which will guide patients as to where they may find, and therefore avoid, the identified allergen. It is useful to make a note of identified allergens for checking products when shopping.  Most countries mandate that allergen constituents appear within or on the packaging or several types of product, particularly personal care items. The print can be very small, and cosmetic manufacturer’s websites usually list constituents, are up to date and easier to read.

Photopatch tests

Some people will tolerate a product applied to their covered skin, but will react to the product on exposure to light (photocontact dermatitis). This can be investigated by photopatch testing; this may be relevant to some fragrances, antiseptics, plant allergens, and sunscreen reactions.

Two identical panels of photopatch allergens are applied to the back, and at 48 hours only one of the panels is exposed to ultraviolet light. The patches are read at 96 hrs. Photocontact dermatitis is diagnosed when only the exposed allergen produces a positive reaction.

Adverse reactions to patch tests

Positive reactions produce small itchy patches of eczema. At the end of the testing, this can be treated with a topical steroid.

Other adverse reactions include:

  • Severe local reactions with local blistering — most notorious with the hair dye allergen PPD; if this is suspected, an initial patch test with a low strength of PPD can be used
  • Post-inflammatory pigmentation
  • Flareup of the initial eczema at sites distant from the patch test reaction
  • Tape reactions — hypoallergenic tape is used but rarely people will react to this
  • Sensitisation — rarely the application of the allergen may result in sensitisation during the patch testing; this may produce a positive reaction in about 10 to 14 days after the patch tests are applied
  • An “angry back” reaction — if the dermatitis is very active at the time of patch testing, multiple positive patch tests may arise; these are difficult to interpret and re-patch testing is usually required when the eczema is more quiescent. 

Adverse reactions to patch tests



  • Johnston GA, Exton LS, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of contact dermatitis 2017. Br J Dermatol. 2017;176(2):317–29. doi:10.1111/bjd.15239. Journal
  • Seine AJ, Baird EA, Chan L, et al. A baseline patch test series for New Zealand. Australas J Dermatol. 2021;62(4):489–95. doi:10.1111/ajd.13673. Journal

On DermNet

Other websites

Books about skin diseases


Related information

Sign up to the newsletter